Analysis of 25 Surgical Cases of Thymic Neuroendocrine Tumors and Thymic Carcinoma-Reference-Cited by-同舟云学术

Analysis of 25 Surgical Cases of Thymic Neuroendocrine Tumors and Thymic Carcinoma

Published:2023-11-30 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Midorikawa Kensuke¹,Miyahara So¹,Nishino Nanako¹,Ueda Yuichirou¹,Waseda Ryuichi¹,Shiraishi Takeshi¹,Sato Toshihiko¹

Affiliation:

1. Fukuoka University School of Medicine

Abstract

Abstract Background The purpose of this study was to evaluate the clinicopathological characteristics of patients who underwent surgical resection for thymic neuroendocrine tumors (TNET) or thymic carcinoma. Methods In this study, we retrospectively evaluated the clinicopathological characteristics of our surgical patients at Fukuoka University Hospital from January 1995 to December 2018. Results There were nine cases of TNET and 16 cases of thymic carcinoma. Regarding the pathological type, the TNET group included three atypical carcinoid cases, two large cell neuroendocrine tumor cases, two small cell carcinoma cases, and two other cases. The thymic carcinoma group included 15 squamous carcinoma cases and one case of adenosquamous carcinoma. Based on the Masaoka-Koga staging system, six TNET cases and 11 thymic carcinoma cases were stage III or IV. The complete resection rate was 77% in the TNET group and 81% in the thymic carcinoma group. Additional chemotherapy and/or radiotherapy was performed in five cases of TNET and 11 cases of thymic carcinoma. The five-year survival rate and five-year disease-free survival rate were 87.5% and 75.0% in the TNET group and 58.9% and 57.1% in the thymic carcinoma group, respectively, with no significant difference between the two groups (P = 0.248 and P = 0.894, respectively). In the univariate analysis, complete resection was a statistically significant prognostic factor (P = 0.017). Conclusion In this study, no difference in prognosis was observed between TNET and thymic carcinomas. To understand the characteristics of these tumors, further case accumulation and multicenter clinical studies are needed. (243words)

Publisher

Research Square Platform LLC

Reference36 articles.

1. Primary neuroendocrinetumors of the thymus: A multicenter experience of 35 patients;Cardillo G;Ann Thorac Surg,2012

2. Outcome of primary neuroendocrine tumors of the thymus: a joint analysis of the international thymic malignancy interest group and the European Society of Thoracic Surgeons databases;Filosso PL;J Thorac Cardiovasc Surg,2015

3. Marx A, Shimosato Y, Kuo TT, Chan JK, Travis WD, Wick WR et al. Thymic neuroendocrine tumours. In: Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, editors World Health Organization Classification of Tumours: Pathology and Genetics of Tumoours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press;2004:188–95.

4. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart, Fourth Edition. France: International Agency for Research on Cancer.2015;234–242.

5. WHO Classification of Tumours Editorial Board. Thoracic tumours. WHO Classification of Tumours. Fifth Edition. ed. Lyon, France: International Agency for Research on Cancer; 2021.